Greg Mirigian

Greg joined JenaValve in 2016, bringing over 25 years of proven leadership experience in the design and development of medical device technologies in neurovascular, peripheral vascular and cardiovascular markets. Greg has been an instrumental leader in the development of JenaValve’s transcatheter heart valve system and future technology pipeline.

Greg has a dedicated career in developing innovative medical technology and brings a breadth of product development experience to the organization. Before joining JenaValve, Greg established a successful R&D consulting firm assisting clients ranging from medical device start-ups to Fortune 500 corporations in the development and commercialization of various novel interventional devices. He was previously Chief Technology Officer for INCUMEDx, an R&D-focused medical device incubator of various neurovascular/cardiovascular devices and surgical implants. Greg also held several leadership roles over 16 years at Boston Scientific Neurovascular and Boston Scientific Japan in R&D and Advanced Technology groups in developing multiple, commercial catheter, guidewire, and embolic coil products.

Greg is an innovator and has over 30 issued patents in various medical device fields. He received his education from San Jose State University and earned a B.S. in Mechanical Engineering with a minor in Business.